TY - JOUR
T1 - Baseline characteristics of participants in the NAVKIDS(2) trial
T2 - a patient navigator program in children with chronic kidney disease
AU - Guha, Chandana
AU - Khalid, Rabia
AU - van Zwieten, Anita
AU - Francis, Anna
AU - Hawley, Carmel M.
AU - Jaure, Allison
AU - Teixeira-Pinto, Armando
AU - Mallard, Alistair R.
AU - Bernier-Jean, Amelie
AU - Johnson, David W.
AU - Hahn, Deirdre
AU - Reidlinger, Donna
AU - Pascoe, Elaine M.
AU - Ryan, Elizabeth G.
AU - Mackie, Fiona
AU - McCarthy, Hugh J.
AU - Craig, Jonathan C.
AU - Varghese, Julie
AU - Kiriwandeniya, Charani
AU - Howard, Kirsten
AU - Larkins, Nicholas G.
AU - Macauley, Luke
AU - Walker, Amanda
AU - Howell, Martin
AU - Irving, Michelle
AU - Caldwell, Patrina H. Y.
AU - Woodleigh, Reginald
AU - Jesudason, Shilpanjali
AU - Carter, Simon A.
AU - Kennedy, Sean E.
AU - Alexander, Stephen
AU - McTaggart, Steven
AU - Wong, Germaine
PY - 2023/5
Y1 - 2023/5
N2 - Background Children with chronic kidney disease (CKD) require multidisciplinary care to meet their complex healthcare needs. Patient navigators are trained non-medical personnel who assist patients and caregivers to overcome barriers to accessing health services through care coordination. This trial aims to determine the effectiveness of a patient navigator program in children with CKD.Methods The NAVKIDS(2) trial is a multi-center, waitlisted, randomized controlled trial of patient navigators in children with CKD conducted at five sites across Australia. Children (0-16 years) with CKD from low socioeconomic status rural or remote areas were randomized to an intervention group or a waitlisted control group (to receive intervention after 6 months). The study primary and secondary endpoints include the self-rated health (SRH) (primary), and utility-based quality of life, progression of kidney dysfunction of the child, SRH, and satisfaction with healthcare of the caregiver at 6 months post-randomization.Results The trial completed recruitment in October 2021 with expected completion of follow-up by October 2022. There were 162 patients enrolled with 80 and 82 patients randomized to the immediate intervention and waitlisted groups, respectively. Fifty-eight (36%) participants were from regional/remote areas, with a median (IQR) age of 9.5 (5.0, 13.0) years, 46% were of European Australian ethnicity, and 65% were male. A total of 109 children (67%) had CKD stages 1-5, 42 (26%) were transplant recipients, and 11 (7%) were receiving dialysis.Conclusion The NAVKIDS(2) trial is designed to evaluate the effectiveness of patient navigation in children with CKD from families experiencing socioeconomic disadvantage.
AB - Background Children with chronic kidney disease (CKD) require multidisciplinary care to meet their complex healthcare needs. Patient navigators are trained non-medical personnel who assist patients and caregivers to overcome barriers to accessing health services through care coordination. This trial aims to determine the effectiveness of a patient navigator program in children with CKD.Methods The NAVKIDS(2) trial is a multi-center, waitlisted, randomized controlled trial of patient navigators in children with CKD conducted at five sites across Australia. Children (0-16 years) with CKD from low socioeconomic status rural or remote areas were randomized to an intervention group or a waitlisted control group (to receive intervention after 6 months). The study primary and secondary endpoints include the self-rated health (SRH) (primary), and utility-based quality of life, progression of kidney dysfunction of the child, SRH, and satisfaction with healthcare of the caregiver at 6 months post-randomization.Results The trial completed recruitment in October 2021 with expected completion of follow-up by October 2022. There were 162 patients enrolled with 80 and 82 patients randomized to the immediate intervention and waitlisted groups, respectively. Fifty-eight (36%) participants were from regional/remote areas, with a median (IQR) age of 9.5 (5.0, 13.0) years, 46% were of European Australian ethnicity, and 65% were male. A total of 109 children (67%) had CKD stages 1-5, 42 (26%) were transplant recipients, and 11 (7%) were receiving dialysis.Conclusion The NAVKIDS(2) trial is designed to evaluate the effectiveness of patient navigation in children with CKD from families experiencing socioeconomic disadvantage.
KW - Patient navigator
KW - Chronic kidney disease
KW - Children
KW - Adolescents
KW - Socioeconomic status
KW - Social determinants of health
KW - SELF-RATED HEALTH
KW - QUALITY-OF-LIFE
KW - YOUNG-ADULTS
KW - CARE
KW - ASTHMA
KW - INTERVENTION
KW - ASSOCIATION
KW - ADOLESCENTS
KW - DISPARITIES
KW - TRANSITION
UR - http://www.scopus.com/inward/record.url?scp=85140322657&partnerID=8YFLogxK
U2 - 10.1007/s00467-022-05772-2
DO - 10.1007/s00467-022-05772-2
M3 - Article
C2 - 36264432
SN - 0931-041X
VL - 38
SP - 1577
EP - 1590
JO - Pediatric Nephrology
JF - Pediatric Nephrology
IS - 5
ER -